KDM2B and glioblastoma: Of note, the knockdown of KDM2B in glioblastoma cells decreases the levels of H3K36me2, reduces the number of proliferating cells and increase DNA damage accumulation, supporting KDM2B role in glioblastoma SC maintenance (Staberg et al., 2018).